We have collected information about Qlt Punctal Plug Delivery System for you. Follow the links to find out details on Qlt Punctal Plug Delivery System.
https://eyewire.news/articles/20121025-qlt_shows_positive_efficacy_trends_from_data_in_plug_combinations_in_phase_2_studies_for_glaucoma_using_latanoprost_punctal_plug_delivery_system/
QLT Inc. announced that results from two phase 2 clinical studies, PPL GLAU 12 and PPL GLAU 13, demonstrate positive trends (with statistically and clinically significant findings) on the efficacy and safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with ocular hypertension (OH) and open-angle glaucoma (OAG).
https://www.thestreet.com/investing/stocks/qlts-ceo-discusses-latanoprost-punctal-plug-delivery-system-conference-call-transcript-11278458
Oct 16, 2011 · Today’s call will review QLT’s Phase II study for glaucoma using the Latanoprost Punctal Plug Delivery System. If you have not yet received a copy of our press release, you can find it by ...
https://ir.novelion.com/news-releases/news-release-details/qlt-announces-phase-ii-clinical-trial-results-olopatadine
QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System (O-PPDS) VANCOUVER, British Columbia, Feb 9, 2011 (GlobeNewswire via COMTEX) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O-PPDS).
https://www.bionity.com/en/companies/17534/qlt-inc.html
QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension. QLT Inc. announced the initiation of patient recruitment into its "CORE" study, a phase II trial being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. ("QPD"), to evaluate the preliminary efficacy and safety of its latanoprost punctal plug delivery system for the treatme ...
https://www.biospace.com/article/releases/qlt-inc-initiates-phase-ii-study-of-punctal-plug-drug-delivery-system-for-glaucoma-and-ocular-hypertension-/
Mar 31, 2008 · QLT Inc. Initiates Phase II Study of Punctal Plug Drug Delivery System for Glaucoma & Ocular Hypertension - read this article along with other careers information, tips and advice on BioSpace
https://www.fiercepharma.com/drug-delivery/qlt-reports-success-eye-drug-delivery-analyst-skeptical
Aug 30, 2011 · Vancouver-based QLT ... is reporting that its latanoprost punctal plug delivery system is certainly ... QLT reports success with eye drug delivery, analyst skeptical. ...
https://www.fiercebiotech.com/biotech/qlt-shows-positive-4-week-efficacy-phase-ii-study-for-glaucoma-using-latanoprost-punctal
Aug 30, 2011 · QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System Aug 30, 2011 1:13pm -- First reported demonstration of a …
Searching for Qlt Punctal Plug Delivery System?
You can just click the links above. The data is collected for you.
